Open Access

Metabolic changes in cardiomyocytes during sepsis

Critical Care201317:186

https://doi.org/10.1186/1364-8535-17-186

Published: 20 September 2013

Abstract

Different types of shock induce distinct metabolic changes. The myocardium at rest utilizes free fatty acids as its primary energy source, a mechanism that changes to aerobic glycolysis during sepsis and is in contrast to hemorrhagic shock. The immune system also uses this mechanism, changing its substrate utilization to activate innate and adaptive cells. Cardiomyocytes share a number of features similar to antigen-presenting cells and may use this mechanism to augment the immune response at the reversible expense of cardiac function.

Cardiomyocyte metabolism changes in response to different types of shock. Chew and colleagues [1] in the previous issue of Critical Care used microdialysis to measure metabolites within cardiac and skeletal muscle during endotoxemia. They found that endotoxemic shock induces metabolic changes in cardiac and skeletal muscle cells that do not occur during hemorrhagic shock. In particular, myocardial and skeletal muscle glucose concentrations were markedly decreased during endotoxemic shock. While lactate increased in both forms of shock, pyruvate levels also increased during endotoxemia, suggesting that elevated lactate levels were not due to anaerobic metabolism, in accord with the observations of Cunnion and colleagues [2]. Muscle pyruvate levels did not increase to the same extent during hemorrhagic shock, suggesting that increased lactate was linked to anaerobic metabolism occurring in this form of shock.

This study demonstrated novel findings on the metabolic differences between two pathological shock states and re-demonstrated the metabolic flexibility of the myocardium. The profoundly low local glucose concentration in myocardium and skeletal muscle during endotoxemic shock with preservation of the lactate to pyruvate ratios suggests lactate utilization and/or differences in the Krebs cycle. Another interesting finding was the ability of skeletal muscle to preserve the lactate to pyruvate ratio during endotoxemic but not hemorrhagic shock, reflecting again the different lactate fates and perhaps the different mitochondrial densities between myocardium and skeletal muscle.

Sepsis induces significant changes in myocardial metabolism, including a reduction in the oxygen extraction ratio of the myocardium [2, 3] and a shift in metabolic substrate from using free fatty acids to increased utilization of lactate. To understand the differences in myocardial and skeletal muscle metabolism observed by Chew and colleagues [1], we explore changes in substrate metabolism observed during a septic inflammatory response.

Sepsis is unique amongst types of shock in that it is the result of a complex interaction between the infecting microorganism and the host immune, inflammatory and coagulation responses. The host innate immune response is triggered through interaction of pathogen molecules with innate immune receptors with subsequent release of pro- and anti-inflammatory cytokines, stimulation of adaptive immunity, and activation of the coagulation system. Recent data suggest that septic shock may have unique effects on substrate utilization with accelerated glucose metabolism, despite compble pyruvate and lactate levels [1]. Reversible cardiomyocyte hypocontractility also occurs, possibly related to hibernation in order to maintain myocyte viability by limiting oxygen consumption, energy requirements and ATP. Whether a direct metabolic link connecting metabolic substrates and contractility exists remains to be demonstrated. It is notable, however, that Chew and colleagues [1] observed a significant drop in ejection fraction and impaired ventricular relaxation.

Cardiomyocytes possess the ability to act as substrate 'omnivores', changing their energy substrate in response to demand, ischemia and inflammatory stimuli. Prior studies have demonstrated the alteration in oxidative phosphorylation that occurs within mitochondria during sepsis, despite adequate oxygen availability and the preservation of ATP [4]. This also occurs during ischemia, likely from a different mechanism with intracellular ATP maintained by increased aerobic glycolysis. Concurrently, glucose transporters GLUT1 and GLUT4 increase glucose uptake with glycogen deposition in the cells [5].

The change in myocardial metabolism is not unique, but also is a function of the immune system whereby immune cells must switch from a resting quiescent state to an active state. Accelerated rates of glycolysis can occur through lipopolysaccharide activation of macrophages and dendritic cells through Toll-like receptor 4 (TLR4) in M1 inflammatory macrophages and T-helper 17 lymphocytes [6, 7]. On the other hand, cells that limit inflammation, such as regulatory T cells, M2 anti-inflammatory macrophages and quiescent memory T cells that carry the CD8 antigen, exhibit oxidative metabolism with more limited rates of glycolysis [8, 9]. This process is very energy demanding and it has been shown that activated T cells can increase glucose uptake 20- to 40-fold in preption to divide [10]. Amino acid and lipid metabolism is suppressed in order to permit cell expansion and hexokinase activity is increased, an enzyme involved in both glycolysis and the catabolic pentose phosphate pathway [11]. Free fatty acids are also activators of NF-κB through TLR4 signaling in adipocytes and skeletal muscle, and may have a similar effect in the myocardium [12]. Therefore, aerobic glycolysis is required for immune activation of macrophages, dendritic cells and T-cell effectors, but has little effect on cell proliferation or survival [6]. In activated T cells, this process may be regulated by GADPH binding to AU-rich elements in interferon-γ mRNA, thereby controlling its cytokine translation [13].

Cardiomyocytes share a number of features analogous to the antigen-presenting cells, including expression of TLRs [14, 15]. In response to TLR activation, cardiomyocytes express many pro- and anti-inflammatory molecules, including cytokines (for example, tumor necrosis factor-α, interleukin-1β), chemokines, cell surface adhesions molecules, triggering of apoptotic pathways and increased expression of calcium channel binding proteins. Intercellular adhesion molecule 1 binds the cardiomyocyte cytoskeleton, disrupting normal intracellular calcium release and resulting in decreased contractility [16]. Calcium channel binding proteins S100A8 and S100A9 bind to the sarcoplasmic reticulum calcium channel SERCA2, further decreasing contractility [17]. Lastly, extracellular heat shock protein 70 acts through TLR2 to activate NF-κB and decrease contractility [18]. Therefore, it is not surprising that the changes in myocardial metabolism observed during the septic inflammatory response may share features with changes in metabolism observed in inflammatory cells. It is conceivable that changes in substrate metabolism observed in cardiomyocytes may be due to mechanisms shared with other inflammatory cells. Whether the myocardium decreases contractility to reflect the relatively inefficient process of aerobic glycolysis remains to be solved.

Abbreviations

NF: 

nuclear factor

TLR: 

Tol-like receptor.

Declarations

Authors’ Affiliations

(1)
Centre for Heart and Lung Innovation, St Paul's Hospital and University of British Columbia, Division of Critical Care Medicine

References

  1. Chew MS, Shekare K, Brand BA, Norin C, Barnett AG: Depletion of myocardial glucose is observed during endotoxaemic but not haemorrhagic shock in a porcine model. Crit Care 2013, 17: R164. 10.1186/cc12843PubMed CentralView ArticlePubMedGoogle Scholar
  2. Cunnion RE, Schaer GL, Parker MM, Natanson C, Parrillo JE: The coronary circulation in human septic shock. Circulation 1986, 73: 637-644. 10.1161/01.CIR.73.4.637View ArticlePubMedGoogle Scholar
  3. Dhainaut JF, Huyghebaert MF, Monsallier JF, Lefevre G, Dall'Ava-Santucci J, Brunet F, Villemant D, Carli A, Raichvarg D: Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 1987, 75: 533-541. 10.1161/01.CIR.75.3.533View ArticlePubMedGoogle Scholar
  4. Fink MP: Bench-to-bedside review: Cytopathic hypoxia. Crit Care 2002, 6: 491-499. 10.1186/cc1824PubMed CentralView ArticlePubMedGoogle Scholar
  5. Tian R, Abel ED: Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis. Circulation 2001, 103: 2961-2966. 10.1161/01.CIR.103.24.2961View ArticlePubMedGoogle Scholar
  6. Krawczyk CM, Holowka T, Sun J, Blagih J, Amiel E, DeBerardinis RJ, Cross JR, Jung E, Thompson CB, Jones RG, Pearce EJ: Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 2010, 115: 4742-4749. 10.1182/blood-2009-10-249540PubMed CentralView ArticlePubMedGoogle Scholar
  7. Rodriguez-Prados JC, Traves PG, Cuenca J, Rico D, Aragones J, Martin-Sanz P, Cascante M, Bosca L: Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol 2010, 185: 605-614. 10.4049/jimmunol.0901698View ArticlePubMedGoogle Scholar
  8. Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, Chi H: HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 2011, 208: 1367-1376. 10.1084/jem.20110278PubMed CentralView ArticlePubMedGoogle Scholar
  9. van der Windt GJ, Everts B, Chang CH, Curtis JD, Freitas TC, Amiel E, Pearce EJ, Pearce EL: Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 2012, 36: 68-78. 10.1016/j.immuni.2011.12.007PubMed CentralView ArticlePubMedGoogle Scholar
  10. Greiner EF, Guppy M, Brand K: Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J Biol Chem 1994, 269: 31484-31490.PubMedGoogle Scholar
  11. Fox CJ, Hammerman PS, Thompson CB: Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol 2005, 5: 844-852. 10.1038/nri1710View ArticlePubMedGoogle Scholar
  12. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS: TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116: 3015-3025. 10.1172/JCI28898PubMed CentralView ArticlePubMedGoogle Scholar
  13. Chang CH, Curtis JD, Maggi LB Jr, Faubert B, Villarino AV, O'Sullivan D, Huang SC, van der Windt GJ, Blagih J, Qiu J, Weber JD, Pearce EJ, Jones RG, Pearce EL: Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 2013, 153: 1239-1251. 10.1016/j.cell.2013.05.016PubMed CentralView ArticlePubMedGoogle Scholar
  14. Brown MA, Jones WK: NF-kappaB action in sepsis: the innate immune system and the heart. Front Biosci 2004, 9: 1201-1217. 10.2741/1304View ArticlePubMedGoogle Scholar
  15. Boyd JH, Mathur S, Wang Y, Bateman RM, Walley KR: Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response. Cardiovasc Res 2006, 72: 384-393. 10.1016/j.cardiores.2006.09.011View ArticlePubMedGoogle Scholar
  16. Davani EY, Dorscheid DR, Lee CH, van Breemen C, Walley KR: Novel regulatory mechanism of cardiomyocyte contractility involving ICAM-1 and the cytoskeleton. Am J Physiol Heart Circ Physiol 2004, 287: H1013-H1022. 10.1152/ajpheart.01177.2003View ArticlePubMedGoogle Scholar
  17. Boyd JH, Kan B, Roberts H, Wang Y, Walley KR: S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ Res 2008, 102: 1239-1246. 10.1161/CIRCRESAHA.107.167544View ArticlePubMedGoogle Scholar
  18. Mathur S, Walley KR, Wang Y, Indrambarya T, Boyd JH: Extracellular heat shock protein 70 induces cardiomyocyte inflammation and contractile dysfunction via TLR2. Circ J 2011, 75: 2445-2452. 10.1253/circj.CJ-11-0194View ArticlePubMedGoogle Scholar

Copyright

© BioMed Central Ltd. 2013

Advertisement